GDC-0134
Product Specifications
CAS Number
1637394-01-4
Target
JNK
Related Pathways
MAPK
Bioactivity
GDC-0134, a dual leucine zipper kinase (DLK) inhibitor, exhibits brain penetration properties. It inhibits DLK to prevent neuronal degeneration and block JNK activation, potentially treating amyotrophic lateral sclerosis (ALS) . It has been assessed in a phase 1 study aimed at treating ALS patients.
Smiles
FC1(F)CN(C=2N=C(C=C(N2)C=3C=C(OC(F)F)C(N)=NC3)N4[C@]5(C[C@@](C4)(OC5)[H])[H])CC1
Molecular Formula
C19H20F4N6O2
Molecular Weight
440.4
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Product Datasheet
https://www.targetmol.com/attachment/DataSheet/293082240877854737/T202043
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
ARP56478_P050-HRP 100 µL
PSMD1 Antibody - N-terminal region : HRP (ARP56478_P050-HRP)
Ask
View Details MBS2012226-01 0.01 mg
Recombinant Interleukin 1 Receptor Associated Kinase 2 (IRAK2)
Ask
View Details MBS2012226-02 0.05 mg
Recombinant Interleukin 1 Receptor Associated Kinase 2 (IRAK2)
Ask
View Details MBS2012226-03 0.1 mg
Recombinant Interleukin 1 Receptor Associated Kinase 2 (IRAK2)
Ask
View Details